Literature DB >> 19273214

Multiple activities of a multifaceted receptor: roles of cleaved and soluble uPAR.

Nunzia Montuori1, Pia Ragno.   

Abstract

The urokinase-type plasminogen activator receptor (uPAR) is a GPI-anchored cell-surface receptor involved in many physiological and pathological events that include cell migration and tissue invasion. uPAR traditional role was considered the focusing of uPA proteolytic activity on the cell surface; however, different uPAR activities have been demonstrated in the last years. In fact, cell surface uPAR functionally interacts with integrins, fMLP-receptors (fMLP-Rs) and growth factor receptors, thus regulating cell adhesion, migration and proliferation. uPAR also exists in a soluble form (suPAR) that has been detected in human body fluids. Both cell surface and suPAR can be proteolytically cleaved, thus generating truncated forms lacking the N-terminal domain and exposing the specific sequence able to interact with the fMLP-Rs. The cleaved form of suPAR binds and activates the fMLP-Rs and regulates the activity of MCP-1, RANTES and SDF1 receptors. Here, we review the role that shedding and cleavage could play in regulating uPAR structural/functional interaction with other cell-surface receptors and in uPAR-mediated biological and pathological processes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273214     DOI: 10.2741/3392

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  36 in total

1.  Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion.

Authors:  Andrew S Gilder; Karra A Jones; Jingjing Hu; Lei Wang; Clark C Chen; Bob S Carter; Steven L Gonias
Journal:  J Biol Chem       Date:  2015-04-02       Impact factor: 5.157

2.  c-Src is in the effector pathway linking uPAR and podocyte injury.

Authors:  Jeffrey B Kopp; Jurgen Heymann
Journal:  J Clin Invest       Date:  2019-04-02       Impact factor: 14.808

3.  The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.

Authors:  Nunzia Montuori; Katia Bifulco; Maria Vincenza Carriero; Claudio La Penna; Valeria Visconte; Daniela Alfano; Ada Pesapane; Francesca Wanda Rossi; Salvatore Salzano; Guido Rossi; Pia Ragno
Journal:  Cell Mol Life Sci       Date:  2010-10-24       Impact factor: 9.261

4.  Is there clinical value in measuring suPAR levels in FSGS?

Authors:  Sanja Sever; Howard Trachtman; Changli Wei; Jochen Reiser
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-25       Impact factor: 8.237

5.  NMR structure and action on nicotinic acetylcholine receptors of water-soluble domain of human LYNX1.

Authors:  Ekaterina N Lyukmanova; Zakhar O Shenkarev; Mikhail A Shulepko; Konstantin S Mineev; Dieter D'Hoedt; Igor E Kasheverov; Sergey Yu Filkin; Alexandra P Krivolapova; Helena Janickova; Vladimir Dolezal; Dmitry A Dolgikh; Alexander S Arseniev; Daniel Bertrand; Victor I Tsetlin; Mikhail P Kirpichnikov
Journal:  J Biol Chem       Date:  2011-01-20       Impact factor: 5.157

6.  Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia.

Authors:  Hong Guo; Lan-Xia Zhou; Haizhen Ma; Bei Liu; Juan Cheng; Yun-Yun Ma; Li Zhao
Journal:  Oncol Lett       Date:  2017-05-10       Impact factor: 2.967

7.  Circulating suPAR levels are affected by glomerular filtration rate and proteinuria in primary and secondary glomerulonephritis.

Authors:  Claudio Musetti; Marco Quaglia; Tiziana Cena; Annalisa Chiocchetti; Sara Monti; Nausicaa Clemente; Corrado Magnani; Umberto Dianzani; Piero Stratta
Journal:  J Nephrol       Date:  2014-09-04       Impact factor: 3.902

8.  Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice.

Authors:  Dominique Cathelin; Sandrine Placier; Michael Ploug; Marie-Christine Verpont; Sophie Vandermeersch; Yosu Luque; Alexandre Hertig; Eric Rondeau; Laurent Mesnard
Journal:  J Am Soc Nephrol       Date:  2014-05-01       Impact factor: 10.121

9.  Role of the urokinase plasminogen activator receptor in mediating impaired efferocytosis of anti-SSA/Ro-bound apoptotic cardiocytes: Implications in the pathogenesis of congenital heart block.

Authors:  Paraskevi Briassouli; Elena V Komissarova; Robert M Clancy; Jill P Buyon
Journal:  Circ Res       Date:  2010-06-17       Impact factor: 17.367

Review 10.  Fibrinolytic System and Cancer: Diagnostic and Therapeutic Applications.

Authors:  Niaz Mahmood; Shafaat A Rabbani
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.